Can High-Repetition or High-Intensity training boost walking after stroke?

NCT ID NCT07725211

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether adding either high-repetition task-oriented training or high-intensity gait training to standard neurodevelopmental therapy helps people with chronic stroke walk farther and move more easily. Forty-five participants who had a stroke at least six months ago will be randomly assigned to one of three groups for eight weeks of therapy. The study aims to see which approach, if any, leads to greater improvements in walking capacity and functional mobility.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
high-repetition task-oriented training and high-intensity gait training, added to neurodevelopmental treatment
What this could lead to
If one approach proves superior, it could point toward more effective rehabilitation strategies for regaining walking ability after stroke.
What could go wrong
This is a small, early-phase trial with only 45 participants, so results may not apply broadly. The improvements may be modest and not translate to real-world mobility.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bingol State Hospital - City: Bingöl, Country: Türkiye (listede "Turkey" olarak geçebilir), Zip: 12000

    Bingoel, Center, 12000, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.